PharmaCielo Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCLOF research report →
About the company
PharmaCielo Ltd. , operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition, the company provides telemedicine software solutions.
- CEO
- Marc Lustig
- IPO
- 2019
- Employees
- 268
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $9.40M
- P/E
- -2.99
- P/S
- 5.40
- P/B
- -0.92
- EV/EBITDA
- -32.37
- Div Yield
- 0.00%
- Gross Margin
- 28.97%
- Op Margin
- -146.43%
- Net Margin
- -174.39%
- ROE
- 35.85%
- ROIC
- -116.13%
- Revenue
- $2.60M · -25.21%
- Net Income
- $-3,980,708 · 56.45%
- EPS
- $-0.01 · 90.04%
- Op Income
- $-3,849,437
- FCF YoY
- 55.26%
- 52W High
- $0.12
- 52W Low
- $0.00
- 50D MA
- $0.06
- 200D MA
- $0.04
- Beta
- 0.56
- Avg Volume
- 81.25K
Get TickerSpark's AI analysis on PCLOF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PCLOF coverage
Recent articles, reports, and earnings notes.
No research on PCLOF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PCLOF report →Similar companies
Peers in the same neighborhood.